This inventor holds 2 USPTO granted patents. Top assignees: Cenes Limited, Genes Limited. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Richard Andrew Ewin: Innovator in Morphine Synthesis
Introduction
Richard Andrew Ewin is a notable inventor based in Brighton, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of morphine derivatives. With a total of 2 patents to his name, Ewin's work has the potential to impact pain management therapies.
Latest Patents
Ewin's latest patents focus on a novel method for synthesizing Morphine-6-Glucuronide. The invention involves the reaction of 3-O-pivaloyloxymorphine and methyl 1α,2-ethylorthopivalate-3,4-di-O-pivaloylglucuronate. This innovative approach aims to enhance the efficiency and effectiveness of morphine synthesis, which is crucial for developing pain relief medications.
Career Highlights
Throughout his career, Richard Andrew Ewin has worked with various companies, including Cenes Limited and Genes Limited. His experience in these organizations has allowed him to refine his skills and contribute to advancements in pharmaceutical research.
Collaborations
Ewin has collaborated with notable professionals in his field, including his coworker Philip James Parsons. These partnerships have fostered an environment of innovation and have led to the development of groundbreaking methods in drug synthesis.
Conclusion
Richard Andrew Ewin's contributions to the field of pharmaceutical chemistry, particularly in morphine synthesis, highlight his role as an influential inventor. His innovative methods and collaborations continue to pave the way for advancements in pain management therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile